INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 45h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Results

77,709 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
6
GC
Gibson ChristopherDirector
RXRXRECURSION PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$124K
40.0K sh
Apr 7, 2026
Page 1185 of 1943
← PrevNext →
Apr 8, 2026
traded Apr 7, 2026
+1d
SEC Form 4

Evidence

6
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$198K
3,900 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

5
RM
Ragosa MarkCHIEF FINANCIAL OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise
M—
2,694 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

5
LM
Lin MarkEVP and CFO
SMTCSEMTECH CORP
Grant or award
A—
450 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

5
TE
Tessari EbenCHIEF STRATEGY OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Tax withholding
F$41K
846 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

5
PR
Porter James RichardDirector, President and CEO
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M$454K
16.3K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

5
TE
Tessari EbenCHIEF STRATEGY OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise
M—
2,726 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

5
PR
Porter James RichardDirector, President and CEO
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M$260K
13.7K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

4
PJ
Prahm JeremyChief Investment Officer
FOAFinance of America Companies Inc.
Open-market sale · 10b5-1 plan
SELL$93K
5,228 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

4
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
14.7K sh
Apr 8, 2026Apr 8, 2026
traded Apr 8, 2026
+0dSEC Form 4

Evidence

4
AJ
Allison JonathanChief Administrative Officer
ROOTRoot, Inc.
Open-market sale · 10b5-1 plan
SELL$76K
1,706 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

3
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M—
2,477 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

3
PR
Porter James RichardDirector, President and CEO
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M—
16.3K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

3
PR
Porter James RichardDirector, President and CEO
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M—
13.7K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

3
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$48K
900 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

2
CE
Cowan ElviaSVP, Finance & CAO
PCVXVaxcyte, Inc.
Option exercise · 10b5-1 plan
M$78K
3,000 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
16.7K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

0
Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner
NETCloudflare, Inc.
Derivative conversion · 10b5-1 plan
C—
52.4K sh
Apr 8, 2026Apr 8, 2026
traded Apr 8, 2026
+0dSEC Form 4

Evidence

0
DV
Date Rajeev VDirector
CRCLCircle Internet Group, Inc.
Option exercise · 10b5-1 plan
M—
1,273 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
11.9K sh
Apr 8, 2026Apr 8, 2026
traded Apr 8, 2026
+0dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
14.7K sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

0
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Derivative conversion · 10b5-1 plan
C—
5,000 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

0
CA
Cannestra AnthonyDirector
BZAIBlaize Holdings, Inc.
Option exercise · 10b5-1 plan
M$28K
50.0K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
16.7K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
27.1K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

0
DS
Desmond SeanDirector, CEO & President
NCNOnCino, Inc.
Option exercise · 10b5-1 plan
M$40K
8,065 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

0
DV
Date Rajeev VDirector
CRCLCircle Internet Group, Inc.
Option exercise · 10b5-1 plan
M$204
2,546 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$107K
14.7K sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

0
DM
Doyle MittieChief Medical Officer
AVTXAvalo Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
3,970 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

0
GC
Gibson ChristopherDirector
RXRXRECURSION PHARMACEUTICALS, INC.
Derivative conversion · 10b5-1 plan
C—
40.0K sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
6,250 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

0
CE
Cowan ElviaSVP, Finance & CAO
PCVXVaxcyte, Inc.
Option exercise · 10b5-1 plan
M—
3,000 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

0
FA
Feuardent Moreira AndreasChief Innovation Officer
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M$100
10.0K sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

0
DV
Date Rajeev VDirector
CRCLCircle Internet Group, Inc.
Option exercise · 10b5-1 plan
M—
2,546 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
14.7K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

0
Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner
NETCloudflare, Inc.
Derivative conversion · 10b5-1 plan
C—
52.4K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

0
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
225.0K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

0
Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner
NETCloudflare, Inc.
Derivative conversion · 10b5-1 plan
C—
52.4K sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

0
Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner
NETCloudflare, Inc.
Derivative conversion · 10b5-1 plan
C—
52.4K sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
100.0K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence